Deep Genomics Company
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
Investors
.jpeg)
.jpg)
Technology:
P4 Medicine
Industry:
Early Drug Development
Headquarters:
Toronto, Ontario, Canada
Founded Date:
01.01.2014
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
10
Total Funding:
$57 M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership